Pet DRx Corporation (VETSU) news stock charts
Pet DRx Corporation (VETSU) Investment Summary:
We were incorporated in Delaware on June 10, 2005 as Echo Healthcare Acquisition Corp. (“Echo”), a blank check company formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition or other similar business combination one or more domestic or international operating businesses in the healthcare industry. A registration statement for our initial public offering was declared effective on March 17, 2006. On March 22, 2006, we consummated our initial public offering of 6,250,000 units. On March 27, 2006, we consummated the closing of an additional 937,500 units that were subject to the underwriters’ over-allotment option. Each unit consists of one share of common stock, par value $0.0001 per share, and one warrant. Each warrant entitles the holder to purchase from us one share of our common stock at an exercise price of $6.00 per share. Our common stock and warrants began trading separately on June 6, 2006. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f04%2f04%2f0001188112-08-001219.html#FIS_BUSINESS"PET DRX CORP (VETSU:NASDAQ)
Snapshot of PET DRX CORP (VETSU)
|
OPEN
--
|
PREVIOUS CLOSE
$0.25
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
-- - --
|
52 WEEK LOW
-- - --
|
|
|
MARKET CAP
--
|
AVERAGE VOLUME 10 D
0.0
|
|
|
EPS TTM
--
|
SHARES OUTSTANDING
8.8M
|
|
|
VETSU Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for PET DRX CORP (VETSU)
Pet DRx Corporation reported consolidated unaudited earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported loss before provision/(benefit) for income taxes of $1,786,000, loss from continuing operations of $1,809,000 or $0.08 diluted loss, net loss of $1,809,000 or $0.08 diluted loss on revenue of $15,734,000 as compared to loss before provision/(benefit) for income taxes of $3,004,000, loss from continuing operations of $3,016,000 or $0.13 diluted loss, net loss of $3,172,000 or $0.13 diluted loss on revenue of $17,299,000 for the same period last year. Adjusted EBITDA was $294,000 as compared to adjusted LBITDA of $2,166,000 for the same period last year. For nine months, the company reported loss before provision/(benefit) for income taxes of $9,185,000, loss from continuing operations of $9,213,000 or $0.39 diluted loss, net loss of $9,213,000 or $0.39 diluted loss on revenue of $49,158,000 as compared to loss before provision/(benefit) for income taxes of $11,084,000, loss from continuing operations of $11,067,000 or $0.47 diluted loss, net loss of $11,438,000 or $0.49 diluted loss on revenue of $52,193,000 for the same period last year. Loss from operations was $1,421,000 as compared to $7,249,000 for the same period last year. Adjusted EBITDA was $614,000 as compared to adjusted LBITDA of $5,621,000 for the same period last year. The decrease in revenues of 9.0% and 5.8%, respectively, continues to be primarily due to decreased volume of traffic at the Company's clinics as the California economy remained weak during the first nine months of 2009. The increase in Adjusted EBITDA in 2009 was primarily due to the reduced spending in selling, general, and administrative expenses as compared to the same time period in the previous year as well as improved hospital contribution margins.
The CEO of Pet DRX Corporation, Gene Burleson, said in a conference call, We stay committed to growing this Company through its strategic acquisitions, and as we have improved our current operations, we are in much better position to add facilities to our network, both in other parts of the country, as well as the state of California. While we have no active acquisitions in process, it's still an area that we investigate as opportunities present themselves.
Pet DRx Corporation, Q3 2009 Earnings Call, Nov 16 2009
Pet DRx Corporation financial resources
VETSU Competitors
| Company | Last | Change | |
| No competitor information is available for VETSU. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | VETSU | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.1x |
|
| Price/Book | 0.2x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
VETSU |
||
VETSU transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||